UAE Makes History with Neuralink Trials
The United Arab Emirates is set to make history as the first country outside the United States to host clinical trials of Neuralink’s wireless brain chip technology. Developed by Elon Musk’s pioneering company, Neuralink, the device is designed to significantly improve the quality of life for individuals suffering from paralysis and other neurological conditions.
The ambitious clinical trial, named UAE-PRIME, marks a major collaboration between the Department of Health Abu Dhabi, Cleveland Clinic Abu Dhabi, and Neuralink. This initiative underscores the UAE’s growing role as a global leader in cutting-edge healthcare innovation and biotechnology.
Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health Abu Dhabi, lauded the partnership as a transformative milestone for the region’s life sciences sector. “This collaboration places Abu Dhabi at the forefront of neurotechnology research and reflects our commitment to shaping the future of medical science,” he stated.
Elon Musk confirmed the partnership via a post on X (formerly known as Twitter), expressing confidence in the UAE’s vision and infrastructure to support such a revolutionary trial.
With this move, the UAE continues to position itself as a hub for advanced medical research and technology, further attracting global investment and talent in the field of neuroscience and digital health.